Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

India's Cipla in drug supply talks with GSK, Teva
Reuters
Monday, January 4, 2010 - 9:24am
tags:
GSK, Teva Pharmaceuticals, Boehringer Ingelheim, Cipla, India
Cipher to seek U.S. approval for pain treatment
Reuters
Monday, January 4, 2010 - 9:23am
tags:
Cipher Pharmaceuticals, Canada, FDA
Pfizer's $1.3B Esperion Loss Contained a $426M Tax Win
BNET Pharma
Monday, January 4, 2010 - 9:18am
tags:
Pfizer, Esperion
InterMune gets FDA priority review for pirfenidone
Marketwatch
Monday, January 4, 2010 - 8:49am
tags:
FDA, InterMune, pirfenidone
Senate Likely to Have Edge as Democrats Craft Final Health Bill
Bloomberg
Monday, January 4, 2010 - 8:47am
tags:
healthcare bill, healthcare reform
Pfizer Discontinues Cancer Drug: Biotech's Recently Missed Targets
Seeking Alpha
Monday, January 4, 2010 - 8:45am
tags:
Pfizer, Arena Pharmaceuticals, JNJ, Merck, Trimeris, figitumumab
Novartis Looks to Buy the Rest of Alcon
TheStreet.com
Monday, January 4, 2010 - 8:42am
tags:
Novartis, Alcon, M&A
Abbott's purchases bolster future
Chicago Tribune, IL
Sunday, January 3, 2010 - 11:46am
tags:
Abbott Laboratories, M&A, Solvay
Pfizer Must Face Menopause-Drug Award, Court Finds
Bloomberg
Sunday, January 3, 2010 - 11:44am
tags:
Pfizer, settlements, Provera
Facing Stunted Growth in ADHD Market, Shire Clicks on Twitter
BNET Pharma
Sunday, January 3, 2010 - 11:42am
tags:
Shire, ADHD, social media, twitter, Vyvanase
2010 FDA Decisions to Watch
Motley Fool
Sunday, January 3, 2010 - 11:39am
tags:
FDA, Pfizer, Nektar, MannKind, Afresa, Eli Lilly, Amylin, Dendreon, Vivus, Alkermes, Arena Pharmaceuticals, Orexigen
The FDA (Still) Hates Antibiotic Makers
Motley Fool
Sunday, January 3, 2010 - 11:37am
tags:
FDA, antibiotics, JNJ, ceftobiprole, Wyeth, Pfizer, Theravance
Will Biodel Be the Comeback Company of 2010?
Minyanville
Sunday, January 3, 2010 - 11:36am
tags:
Biodel, Viaject
AstraZeneca Strengthens Pipeline with Novexel, Forest Lab Deals
Seeking Alpha
Thursday, December 31, 2009 - 9:57am
tags:
Novexel, Forest Labs, AstraZeneca
Eli Lilly & Co. heiress Ruth Lilly dies at 94
Yahoo/AP
Thursday, December 31, 2009 - 9:32am
tags:
Eli Lilly
Is a Weak Dollar the Best Healthcare Bet?
TheStreet.com
Thursday, December 31, 2009 - 9:24am
tags:
Pfizer Pflubs -- You Expected Otherwise?
Motley Fool
Thursday, December 31, 2009 - 9:19am
tags:
Pfizer, figitumumab
King Pharmaceuticals: A Look Ahead to Dec 2009 Quarterly Results
Seeking Alpha
Thursday, December 31, 2009 - 9:18am
tags:
King, earnings
Pfizer Provides U.S. Regulatory Update On Prevnar 13 Vaccine
Yahoo
Wednesday, December 30, 2009 - 5:18pm
tags:
vaccines, Prevnar 13, Pfizer
Good News for Vical Candidate
Yahoo/Zacks.com
Wednesday, December 30, 2009 - 5:18pm
tags:
Vical, FDA, cancer, Allovectin-7

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.